secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stimcell Energetics Inc. (STME)
CIK:        0001493712
Form:       8-K
Filed at:   2024-11-05T23:59:59+00:00
Accession:  0001393905-24-000378
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cell MedX completes 1:15 reverse stock split and rebrands as Stimcell Energetics
--------------------------------------------------------------------------------

- Reverse split 1:15 effective Nov 1, 2024; shares outstanding reduced from ~297M to ~19.8M.
- Authorized capital reduced from 7.5B to 500M shares of common, par value $0.001.
- Name changed from Cell MedX Corp. to Stimcell Energetics Inc.
- Symbol will trade as "CMXCD" for 20 business days starting Nov 5, then seek new symbol.
- New website launched at www.StimCell.com for investor and clinical trial info.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493712/000139390524000378/0001393905-24-000378-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493712/000139390524000378/cmxc-20241101.htm
  HTML page:      https://secwatch.observer/filing/0001393905-24-000378

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer